September 25, 2020
Article
From the Chairman
In this special hematology focused issue of CURE® we look at all the promising treatments and research for both adults and children with blood cancers.
September 25, 2020
Article
Editor's Page
Mantle Cell Lymphoma (MCL), as described in this issue of CURE®, has an interesting and inspiring story. It was one of the first cancers known to have a genetic abnormality-chromosomal translocation t(11;14).
September 24, 2020
Article
Research News and Updates
Finding the best care team can make all the difference for patients with diseases like multiple myeloma.
September 24, 2020
Article
Speaking Out
Clinical trials lead to new cancer treatments — and can give a patient access to effective drugs years before they’re made available to the public.
September 23, 2020
Article
Feature
For years, childhood blood cancers were understudied forcing patients’ treatments into a one size-fits-all approach. But new efforts are changing that.
September 23, 2020
Article
Feature
Weighing the cost of CAR-T cell therapy in treating blood cancers is a finical burden for many patients with blood cancer.
September 22, 2020
Article
Feature
Exciting advances in treatment options for patients with mantle cell lymphoma are greatly improving the outlook for long-term remissions.
September 22, 2020
Article
Research News and Updates
CAR-T Cell therapy is expanding in the field of blood cancers, but it comes with a host of side effects patients need to look out for. One study is looking to get ahead of the side effect curve for patients about to undergo CAR-T cell therapy.